ELK3-CXCL16 axis determines natural killer cell cytotoxicity via the chemotactic activity of CXCL16 in triple negative breast cancer
Triple-negative breast cancer (TNBC) is the most challenging subtype of breast cancer because of its aggressive behavior and the limited therapeutic strategies available. In the last decade, immunotherapy has become a promising treatment to prolong survival in advanced solid cancers including TNBC....
Saved in:
| Main Authors: | Hae-Yun Jung, Dae-Keum Lee, Minwook Lee, Seung Hee Choi, Joo Dong Park, Eun-Su Ko, Jongwon Lee, Kyung-Soon Park |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Taylor & Francis Group
2023-12-01
|
| Series: | OncoImmunology |
| Subjects: | |
| Online Access: | https://www.tandfonline.com/doi/10.1080/2162402X.2023.2190671 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Biomarker Significance of Serum CXCL8, CXCL10 and CXCL16 in Breast Tumors of Iraqi Patients
by: Aseel F Khalaf, et al.
Published: (2020-03-01) -
ELK3-CYFIP2 axis-mediated actin remodeling modulates metastasis and natural killer cell responses in triple-negative breast cancer
by: Seung Hee Choi, et al.
Published: (2025-02-01) -
Lower Number and Percentage of Activated Natural Killer Cells in Colorectal Cancer Patients
by: Amie Vidyani, et al.
Published: (2023-01-01) -
Nanomaterial assisted natural killer cell therapy
by: Xuan Yu, et al.
Published: (2025-05-01) -
Does a natural killer need a CAR?
by: Kangbo Wang, et al.
Published: (2025-06-01)